Akso Health Group Stock Beta
| AHG Stock | USD 1.33 0.04 2.92% |
Akso Health Group fundamentals help investors to digest information that contributes to Akso Health's financial success or failures. It also enables traders to predict the movement of Akso Stock. The fundamental analysis module provides a way to measure Akso Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akso Health stock.
Akso |
Akso Health Group Company Beta Analysis
Akso Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Akso Health Beta | 0.2 |
Most of Akso Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akso Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Akso Health Group has a Beta of 0.195. This is 76.22% lower than that of the Health Care Equipment & Supplies sector and 82.89% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Akso Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akso Health's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akso Health could also be used in its relative valuation, which is a method of valuing Akso Health by comparing valuation metrics of similar companies.Akso Health is currently under evaluation in beta category among its peers.
As returns on the market increase, Akso Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Akso Health is expected to be smaller as well.
Akso Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0665 | ||||
| Operating Margin | (4.16) % | ||||
| Current Valuation | 537.52 M | ||||
| Shares Outstanding | 398.82 M | ||||
| Shares Owned By Institutions | 0.07 % | ||||
| Number Of Shares Shorted | 63.66 K | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 224.96 X | ||||
| Revenue | 2.41 M | ||||
| Gross Profit | 1.27 M | ||||
| EBITDA | (8.5 M) | ||||
| Net Income | (9.12 M) | ||||
| Cash And Equivalents | 15.46 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.72 X | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | 1.35 M | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Beta | 0.2 | ||||
| Market Capitalization | 350.96 M | ||||
| Total Asset | 142.02 M | ||||
| Retained Earnings | (63.93 M) | ||||
| Working Capital | 138.42 M | ||||
| Net Asset | 142.02 M |
About Akso Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akso Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akso Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akso Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out Akso Health Piotroski F Score and Akso Health Altman Z Score analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.